Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | OGT to launch new cancer focused CytoSure™ array at CCMC meetingReliable CCMC-standardised array for CNV and LOH detection in haematological malignancies and solid tumours
By: Oxford Gene Technology The new CytoSure™ Consortium Cancer +SNP array allows the simultaneous detection of copy number variation (CNV) and loss of heterozygosity (LOH), with a SNP resolution that enables reporting of LOH at 10Mb. Focusing on content recommended by the CCMC, an international organisation of clinical cytogeneticists, molecular cytogeneticists and molecular pathologists, this targeted array covers over 500 cancer genes and 130 cancer-associated genomic regions for haematological malignancies and solid tumours. The CCMC-approved standardised array design is intended to improve clinical research quality and promotes collaboration and communication between cancer cytogenomics laboratories. The new array will be the latest addition to a range of OGT microarrays specifically designed for detecting CNV and LOH on a single array for cancer research. This includes the recently released CytoSure Cancer +SNP array (http://www.ogt.com/ James Clough, Executive Vice President Commercial at OGT, said: “The new CytoSure Consortium Cancer +SNP array is part of OGT’s commitment to advancing the field of cytogenetic cancer research. OGT’s collaborations in the design and development of our arrays with international organisations such as the CCMC who are leaders in cancer cytogenetics research, are testament to this. By providing reliable, high-quality CNV and SNP detection for haematological malignancies and solid cancers, these arrays are valuable tools for accurately and efficiently defining the genetic nature of cancers, advancing research into novel and improved therapeutics” Delegates of the CCMC / CAGdb meeting (http://www.cancergenomics.org/ OGT representatives will also be available at booth 4 for the duration of the meeting. For more information on OGT’s solutions for cytogenetic cancer research, please visit www.ogt.com/ For further information, please contact: Oxford Gene Technology, Begbroke Science Park, Begbroke Hill, Woodstock Road, Begbroke, Oxfordshire, OX5 1PF, U.K. T: +44 (0) 1865 856826 ; F: +44 (0) 1865 848684 ; E: contact@ W: www.ogt.com ; End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|